You will be redirected to:
Background
The second COVID-19 project for Keyrus Life Science, with a Canadian sponsor was audited by Health Canada because of the rapid approval COVID-19 products were receiving
Challenge
The only way the audit could be performed was remote. Keyrus Life Science and Health Canada had never done a remote audit previously
Approach
Keyrus Life Science and Health Canada held bi-weekly video meetings, daily communication was increased each day and all parties were copied on all correspondence
Key results
01
Remote audit was efficiently and effectively conducted
02
Keyrus Life Science passed the audit with no corrective action and with zero notes
03
The audit was completed in four weeks
Benefits
Working together, Keyrus Life Science and Health Canada were able to achieve their first remote audit while thoroughly reviewing all elements of the Sponsor's COVID-19 project and finalizing without corrective action and with zero notes
Share this key play
More key plays
Piloting through a pivotal study in cataract eye surgery helping patients recover their vision
Medical device approved for Hearing Loss
Accelerate the compliance process of your product portfolio in line with the new Medical Device Regulation (EU 2017/745)
Accelerate the clinical validation of an anti-Covid treatment, thanks to an agile data management
Lower costs & risks associated with indication extensions, thanks to a robust meta-analysis of clinical data
Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents